Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
Serum levels of the two lactogenic hormones prolactin (PRL) and growth hormone (GH) were compared when determined by radioimmunoassay (RIA) and two-site immunoradiometric (IRMA) assays in 83 normal premenopausal women. The mean values for the PRL and GH results determined by RIA were higher than those obtained by IRMA, despite strong correlations between the two (PRL, r = 0.92; GH, r = 0.79). The lactogenic hormones were also determined together by the Nb2 cell bioassay (BA) in 38 of these same women, and the results compared with the sum of the PRL and GH immunoassays. There was a strong correlation between the BA and RIA (r = 0.75), and the BA/PRL+GH RIA ratio averaged 1.6 +/- 0.5. Corresponding values for IRMA were r = 0.66, and BA/PRL + GH IRMA 3.3 +/- 1.1. Thus, the polyclonal RIA antisera appeared to recognize bioactive hormone components not determined by the double monoclonal antibody IRMA. Another 23 women at risk for familial breast cancer, and 14 cystic breast disease patients were also studied. High BA, but normal RIA results, giving mean ratios of 2.4 +/- 1.1 and 3.6 +/- 3.0 respectively, suggest the presence of a further variant with high bioactivity not detected by RIA in these two clinical situations.
Rose
D P
DP
Division of Nutrition and Endocrinology, Naylor Dana Institute for Disease Prevention, Valhalla, New York.
Berke
B
B
Cohen
L A
LA
D000328:Adult; D001681:Biological Assay; D001943:Breast Neoplasms / Q000097:blood; D005260:Female; D005348:Fibrocystic Breast Disease / Q000097:blood; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D008223:Lymphoma / Q000097:blood; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*; D011863:Radioimmunoassay
D011388:Prolactin; D013006:Growth Hormone